OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Three Potential Tumor Markers Promote Metastasis and Recurrence of Colorectal Cancer by Regulating the Inflammatory Response: ADAM8, LYN, and S100A9
Jiawei Liu, Jing Li, Haolin Du, et al.
Computational and Mathematical Methods in Medicine (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 9
Jiawei Liu, Jing Li, Haolin Du, et al.
Computational and Mathematical Methods in Medicine (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 9
Showing 9 citing articles:
Single-cell Transcriptomics Reveals the Aggressive Landscape of High-Grade Serous Carcinoma and Therapeutic Targets in Tumor Microenvironment
Junfen Xu, Weiguo Lü, Xinyi Wei, et al.
Cancer Letters (2024) Vol. 593, pp. 216928-216928
Open Access | Times Cited: 8
Junfen Xu, Weiguo Lü, Xinyi Wei, et al.
Cancer Letters (2024) Vol. 593, pp. 216928-216928
Open Access | Times Cited: 8
The versatile roles of ADAM8 in cancer cell migration, mechanics, and extracellular matrix remodeling
Claudia Tanja Mierke
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 14
Claudia Tanja Mierke
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 14
The long non-coding RNA NEAT1 contributes to aberrant STAT3 signaling in pancreatic cancer and is regulated by a metalloprotease-disintegrin ADAM8/miR-181a-5p axis
Yutong Gao, Kimia Zandieh, Kai Zhao, et al.
Cellular Oncology (2024)
Open Access | Times Cited: 1
Yutong Gao, Kimia Zandieh, Kai Zhao, et al.
Cellular Oncology (2024)
Open Access | Times Cited: 1
EMT-related gene risk model establishment for prognosis and drug treatment efficiency prediction in hepatocellular carcinoma
Xiaqing Gao, Chun‐Ting Yang, Xiaojun Liu, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Xiaqing Gao, Chun‐Ting Yang, Xiaojun Liu, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Identification of angiogenesis‐related subtypes, the development of a prognosis model, and features of tumor microenvironment in colon cancer
Feifei Wang, Changjing Wang, Baokun Li, et al.
Biotechnology and Applied Biochemistry (2023) Vol. 71, Iss. 1, pp. 45-60
Open Access | Times Cited: 2
Feifei Wang, Changjing Wang, Baokun Li, et al.
Biotechnology and Applied Biochemistry (2023) Vol. 71, Iss. 1, pp. 45-60
Open Access | Times Cited: 2
EMT-related gene risk model establishment for prognosis and drug treatment efficiency prediction in hepatocellular carcinoma
Xiaqing Gao, Chun‐Ting Yang, Xiaojun Liu, et al.
Research Square (Research Square) (2023)
Open Access
Xiaqing Gao, Chun‐Ting Yang, Xiaojun Liu, et al.
Research Square (Research Square) (2023)
Open Access
Development of a 5-mRNAsi-related gene signature to predict the prognosis of colon adenocarcinoma
Haifu Huang, Lin Lu, Y. Li, et al.
PeerJ (2023) Vol. 11, pp. e16477-e16477
Open Access
Haifu Huang, Lin Lu, Y. Li, et al.
PeerJ (2023) Vol. 11, pp. e16477-e16477
Open Access
Retracted: Three Potential Tumor Markers Promote Metastasis and Recurrence of Colorectal Cancer by Regulating the Inflammatory Response: ADAM8, LYN, and S100A9
Computational and Mathematical Methods in Medicine
Computational and Mathematical Methods in Medicine (2023) Vol. 2023, Iss. 1
Open Access
Computational and Mathematical Methods in Medicine
Computational and Mathematical Methods in Medicine (2023) Vol. 2023, Iss. 1
Open Access
Selective Anticancer Effects by Oxyclozanide in Triple-Negative Breast Cancer Expressing S100A9
Hyun Hwan Hwang, Ki Ho Chang, Yi Young Choi, et al.
Drug Targets and Therapeutics (2022) Vol. 1, Iss. 1, pp. 1-11
Closed Access
Hyun Hwan Hwang, Ki Ho Chang, Yi Young Choi, et al.
Drug Targets and Therapeutics (2022) Vol. 1, Iss. 1, pp. 1-11
Closed Access
